An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries-Reference-Cited by-同舟云学术

An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries

Published:2021-03-01 Issue:3 Volume:7 Page:379
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Wells J. Connor¹²,Sharma Shubham¹,Del Paggio Joseph C.³,Hopman Wilma M.⁴,Gyawali Bishal¹²⁴,Mukherji Deborah⁵,Hammad Nazik²,Pramesh C. S.⁶,Aggarwal Ajay⁷⁸,Sullivan Richard⁷,Booth Christopher M.¹²⁴

Affiliation:

1. Division of Cancer Care and Epidemiology, Queen’s University Cancer Research Institute, Kingston, Ontario, Canada

2. Department of Oncology, Queen’s University, Kingston, Ontario, Canada

3. Department of Oncology, Northern Ontario School of Medicine, Thunder Bay, Ontario, Canada

4. Department of Public Health Sciences, Queen’s University, Kingston, Ontario, Canada

5. Department of Hematology/Oncology, American University of Beirut Medical Center, Beirut, Lebanon

6. Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India

7. Institute of Cancer Policy, King’s College London, London, United Kingdom

8. Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2775243/jamaoncology_wells_2021_oi_200110_1615397515.86514.pdf

Reference35 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.;Bray;CA Cancer J Clin,2018

2. Evolution of the randomized controlled trial in oncology over three decades.;Booth;J Clin Oncol,2008

3. Randomized controlled trials in the era of molecular oncology: methodology, biomarkers, and end points.;Kay;Ann Oncol,2012

4. Absolute benefits of medical therapies in phase III clinical trials for breast and colorectal cancer.;Seruga;Ann Oncol,2010

5. Shifting patterns in the interpretation of phase III clinical trial outcomes in advanced non-small-cell lung cancer: the bar is dropping.;Sacher;J Clin Oncol,2014

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Globalization of clinical research in oncology: Status, challenges, and future directions;Journal of Cancer Policy;2024-12

2. Cancer Reporting and the Perspective of Health Workers on Cancer Management in Delta State, Nigeria: Evidence from a Survey;2024-09-04

3. Current advance of nanotechnology in diagnosis and treatment for malignant tumors;Signal Transduction and Targeted Therapy;2024-08-12

4. Clinical Trials in Gastroesophageal Cancers: An Analysis of the Global Landscape of Interventional Trials From ClinicalTrials.gov;JCO Global Oncology;2024-08

5. CIMT 2024: Report on the 21st Annual Meeting of the Association for Cancer Immunotherapy;Human Vaccines & Immunotherapeutics;2024-07-23